The legacy of Viagra and the medicinal industry presents a challenging picture for prospective investors. Initially, copyright's blockbuster drug revolutionized the treatment of erectile dysfunction, producing significant profits and defining the modern pharmaceutical landscape. However, intellectual property expiration and the emergence of alterna